Blood cancer patient outlives prognosis by years after groundbreaking drug trial

The Independent 7 сент. 2026 г., 22:30 Rebecca Whittaker

About 70 per cent of patients who took part in the trial were still alive six years later

Полный текст — у газеты. Мы оставляем только врез.